These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Thoracic SMARCA4-deficient tumors: a clinicopathological analysis of 52 cases with SMARCA4-deficient non-small cell lung cancer and 20 cases with thoracic SMARCA4-deficient undifferentiated tumor. Zhou P; Fu Y; Tang Y; Jiang L; Wang W PeerJ; 2024; 12():e16923. PubMed ID: 38374950 [TBL] [Abstract][Full Text] [Related]
9. [Thoracic Xiong Y; Zhang B; Nie LG; Wu SK; Zhao H; Li D; DI JT Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):351-356. PubMed ID: 37042149 [TBL] [Abstract][Full Text] [Related]
10. SMARCA4/BRG1 protein-deficient thoracic tumors dictate re-examination of small biopsy reporting in non-small cell lung cancer. Mehta A; Bansal D; Tripathi R; Jajodia A J Pathol Transl Med; 2021 Sep; 55(5):307-316. PubMed ID: 34147056 [TBL] [Abstract][Full Text] [Related]
11. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology. Ramalingam P; Croce S; McCluggage WG Histopathology; 2017 Feb; 70(3):359-366. PubMed ID: 27656868 [TBL] [Abstract][Full Text] [Related]
13. A Subset of Thoracic SMARCA4-Deficient Undifferentiated Tumors Express GATA3. Coconubo DM; Wangsiricharoen S; Pettus JR; Linos K; Pinto A; Wang WL; Kerr DA; Cloutier JM Int J Surg Pathol; 2024 Jun; 32(4):684-691. PubMed ID: 37461275 [TBL] [Abstract][Full Text] [Related]
14. Thorahcic SMARCA4-deficient undifferentiated tumors with ganglioneuroma and enchondroma: implications for SLC7A11 and ARID1A expression: a case report. Kito Y; Kawashima K; Saigo C; Hasegawa M; Nomura S; Mikamo T; Hanamatsu Y; Matsuo Y; Takeuchi T Diagn Pathol; 2022 Feb; 17(1):29. PubMed ID: 35151345 [TBL] [Abstract][Full Text] [Related]
15. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion]. Wang WN; Liu XT; Liang YM Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781 [No Abstract] [Full Text] [Related]
16. Diagnosis of thoracic SMARCA4-deficient undifferentiated tumor in cytology. Kezlarian B; Montecalvo J; Bodd FM; Chang JC; Riedel E; White C; Rekhtman N; Sauter JL Cancer Cytopathol; 2023 Aug; 131(8):526-534. PubMed ID: 37278102 [TBL] [Abstract][Full Text] [Related]
17. SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma. Kolin DL; Dong F; Baltay M; Lindeman N; MacConaill L; Nucci MR; Crum CP; Howitt BE Mod Pathol; 2018 Sep; 31(9):1442-1456. PubMed ID: 29700418 [TBL] [Abstract][Full Text] [Related]
18. SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas. Le Loarer F; Watson S; Pierron G; de Montpreville VT; Ballet S; Firmin N; Auguste A; Pissaloux D; Boyault S; Paindavoine S; Dechelotte PJ; Besse B; Vignaud JM; Brevet M; Fadel E; Richer W; Treilleux I; Masliah-Planchon J; Devouassoux-Shisheboran M; Zalcman G; Allory Y; Bourdeaut F; Thivolet-Bejui F; Ranchere-Vince D; Girard N; Lantuejoul S; Galateau-Sallé F; Coindre JM; Leary A; Delattre O; Blay JY; Tirode F Nat Genet; 2015 Oct; 47(10):1200-5. PubMed ID: 26343384 [TBL] [Abstract][Full Text] [Related]
19. Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor. Lin Y; Yu B; Sun H; Zhang H; Hu Z; Zhang Y; Wu Z; Sun S; Zhao X; Yu H; Wu X; Li Y; Wang J; Wang H J Cancer Res Clin Oncol; 2023 Sep; 149(11):8663-8671. PubMed ID: 37115272 [TBL] [Abstract][Full Text] [Related]
20. [SMARCA4-deficient primary thoracic sarcoma:a clinicopathological analysis of five cases]. Zheng MJ; Zheng Q; Wang Y; Shen L; Zhu XZ; Li Y Zhonghua Bing Li Xue Za Zhi; 2019 Jul; 48(7):537-542. PubMed ID: 31288309 [No Abstract] [Full Text] [Related] [Next] [New Search]